▶ 調査レポート

世界の線維筋形成異常の治療市場：市場規模・現状・予測
• 英文タイトル：Global Fibromuscular Dysplasia Treatment Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。世界の線維筋形成異常の治療市場：市場規模・現状・予測 / Global Fibromuscular Dysplasia Treatment Market Size, Status and Forecast 2019-2025 / QYR9N7206資料のイメージです。• レポートコード：QYR9N7206
• 出版社/出版日：QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、106ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ
• 販売価格（消費税別）
  Single User￥577,200 (USD3,900)▷ お問い合わせ
  Enterprise License￥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
当資料は、線維筋形成異常の治療のグローバル市場について調査・分析したレポートで、種類別（手術療法、薬）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・線維筋形成異常の治療の世界市場規模
・主要企業別市場シェア
・線維筋形成異常の治療の世界市場規模：種類別（手術療法、薬）
・線維筋形成異常の治療の世界市場規模：用途別（病院、診療所、その他）
・線維筋形成異常の治療のアメリカ市場規模（種類別、用途別）
・線維筋形成異常の治療のヨーロッパ市場規模（種類別、用途別）
・線維筋形成異常の治療の中国市場規模（種類別、用途別）
・線維筋形成異常の治療の日本市場規模（種類別、用途別）
・線維筋形成異常の治療の東南アジア市場規模（種類別、用途別）
・線維筋形成異常の治療のインド市場規模（種類別、用途別）
・線維筋形成異常の治療の中南米市場規模（種類別、用途別）
・主要企業別分析（企業概要、製品動向、販売量など）
・線維筋形成異常の治療の世界市場予測（2019年-2025年）
・線維筋形成異常の治療の地域別市場予測（2019年-2025年）
...

Fibromuscular dysplasia (FMD) is a disease that causes abnormal cell development in the artery wall, which results in narrowing, i.e., stenosis, and enlargement, i.e., aneurysm of the medium-sized arteries in the body.In 2018, the global Fibromuscular Dysplasia Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Fibromuscular Dysplasia Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Fibromuscular Dysplasia Treatment development in United States, Europe and China.

The key players covered in this study
Pfizer
Sanofi
Bayer
Merck
Novartis
Bristol-Myers Squibb
AstraZeneca
Allergan
Medtronic
BD
Smith & Nephew
Stryker
B. Braun Melsungen
Johnson & Johnson
Hill-Rom
Alkermes Pharma Ireland
Dainippon Sumitomo Pharma

Market segment by Type, the product can be split into
Surgery Therapy
Medication

Market segment by Application, split into
Hospitals
Clinics
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Fibromuscular Dysplasia Treatment status, future forecast, growth opportunity, key market and key players.
To present the Fibromuscular Dysplasia Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Fibromuscular Dysplasia Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Fibromuscular Dysplasia Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Surgery Therapy
1.4.3 Medication
1.5 Market by Application
1.5.1 Global Fibromuscular Dysplasia Treatment Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Fibromuscular Dysplasia Treatment Market Size
2.2 Fibromuscular Dysplasia Treatment Growth Trends by Regions
2.2.1 Fibromuscular Dysplasia Treatment Market Size by Regions (2014-2025)
2.2.2 Fibromuscular Dysplasia Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Fibromuscular Dysplasia Treatment Market Size by Manufacturers
3.1.1 Global Fibromuscular Dysplasia Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Fibromuscular Dysplasia Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Fibromuscular Dysplasia Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Fibromuscular Dysplasia Treatment Key Players Head office and Area Served
3.3 Key Players Fibromuscular Dysplasia Treatment Product/Solution/Service
3.4 Date of Enter into Fibromuscular Dysplasia Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Fibromuscular Dysplasia Treatment Market Size by Type (2014-2019)
4.2 Global Fibromuscular Dysplasia Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Fibromuscular Dysplasia Treatment Market Size (2014-2019)
5.2 Fibromuscular Dysplasia Treatment Key Players in United States
5.3 United States Fibromuscular Dysplasia Treatment Market Size by Type
5.4 United States Fibromuscular Dysplasia Treatment Market Size by Application

6 Europe
6.1 Europe Fibromuscular Dysplasia Treatment Market Size (2014-2019)
6.2 Fibromuscular Dysplasia Treatment Key Players in Europe
6.3 Europe Fibromuscular Dysplasia Treatment Market Size by Type
6.4 Europe Fibromuscular Dysplasia Treatment Market Size by Application

7 China
7.1 China Fibromuscular Dysplasia Treatment Market Size (2014-2019)
7.2 Fibromuscular Dysplasia Treatment Key Players in China
7.3 China Fibromuscular Dysplasia Treatment Market Size by Type
7.4 China Fibromuscular Dysplasia Treatment Market Size by Application

8 Japan
8.1 Japan Fibromuscular Dysplasia Treatment Market Size (2014-2019)
8.2 Fibromuscular Dysplasia Treatment Key Players in Japan
8.3 Japan Fibromuscular Dysplasia Treatment Market Size by Type
8.4 Japan Fibromuscular Dysplasia Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Fibromuscular Dysplasia Treatment Market Size (2014-2019)
9.2 Fibromuscular Dysplasia Treatment Key Players in Southeast Asia
9.3 Southeast Asia Fibromuscular Dysplasia Treatment Market Size by Type
9.4 Southeast Asia Fibromuscular Dysplasia Treatment Market Size by Application

10 India
10.1 India Fibromuscular Dysplasia Treatment Market Size (2014-2019)
10.2 Fibromuscular Dysplasia Treatment Key Players in India
10.3 India Fibromuscular Dysplasia Treatment Market Size by Type
10.4 India Fibromuscular Dysplasia Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Fibromuscular Dysplasia Treatment Market Size (2014-2019)
11.2 Fibromuscular Dysplasia Treatment Key Players in Central & South America
11.3 Central & South America Fibromuscular Dysplasia Treatment Market Size by Type
11.4 Central & South America Fibromuscular Dysplasia Treatment Market Size by Application

12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Fibromuscular Dysplasia Treatment Introduction
12.1.4 Pfizer Revenue in Fibromuscular Dysplasia Treatment Business (2014-2019)
12.1.5 Pfizer Recent Development
12.2 Sanofi
12.2.1 Sanofi Company Details
12.2.2 Company Description and Business Overview
12.2.3 Fibromuscular Dysplasia Treatment Introduction
12.2.4 Sanofi Revenue in Fibromuscular Dysplasia Treatment Business (2014-2019)
12.2.5 Sanofi Recent Development
12.3 Bayer
12.3.1 Bayer Company Details
12.3.2 Company Description and Business Overview
12.3.3 Fibromuscular Dysplasia Treatment Introduction
12.3.4 Bayer Revenue in Fibromuscular Dysplasia Treatment Business (2014-2019)
12.3.5 Bayer Recent Development
12.4 Merck
12.4.1 Merck Company Details
12.4.2 Company Description and Business Overview
12.4.3 Fibromuscular Dysplasia Treatment Introduction
12.4.4 Merck Revenue in Fibromuscular Dysplasia Treatment Business (2014-2019)
12.4.5 Merck Recent Development
12.5 Novartis
12.5.1 Novartis Company Details
12.5.2 Company Description and Business Overview
12.5.3 Fibromuscular Dysplasia Treatment Introduction
12.5.4 Novartis Revenue in Fibromuscular Dysplasia Treatment Business (2014-2019)
12.5.5 Novartis Recent Development
12.6 Bristol-Myers Squibb
12.6.1 Bristol-Myers Squibb Company Details
12.6.2 Company Description and Business Overview
12.6.3 Fibromuscular Dysplasia Treatment Introduction
12.6.4 Bristol-Myers Squibb Revenue in Fibromuscular Dysplasia Treatment Business (2014-2019)
12.6.5 Bristol-Myers Squibb Recent Development
12.7 AstraZeneca
12.7.1 AstraZeneca Company Details
12.7.2 Company Description and Business Overview
12.7.3 Fibromuscular Dysplasia Treatment Introduction
12.7.4 AstraZeneca Revenue in Fibromuscular Dysplasia Treatment Business (2014-2019)
12.7.5 AstraZeneca Recent Development
12.8 Allergan
12.8.1 Allergan Company Details
12.8.2 Company Description and Business Overview
12.8.3 Fibromuscular Dysplasia Treatment Introduction
12.8.4 Allergan Revenue in Fibromuscular Dysplasia Treatment Business (2014-2019)
12.8.5 Allergan Recent Development
12.9 Medtronic
12.9.1 Medtronic Company Details
12.9.2 Company Description and Business Overview
12.9.3 Fibromuscular Dysplasia Treatment Introduction
12.9.4 Medtronic Revenue in Fibromuscular Dysplasia Treatment Business (2014-2019)
12.9.5 Medtronic Recent Development
12.10 BD
12.10.1 BD Company Details
12.10.2 Company Description and Business Overview
12.10.3 Fibromuscular Dysplasia Treatment Introduction
12.10.4 BD Revenue in Fibromuscular Dysplasia Treatment Business (2014-2019)
12.10.5 BD Recent Development
12.11 Smith & Nephew
12.12 Stryker
12.13 B. Braun Melsungen
12.14 Johnson & Johnson
12.15 Hill-Rom
12.16 Alkermes Pharma Ireland
12.17 Dainippon Sumitomo Pharma

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Fibromuscular Dysplasia Treatment Key Market Segments
Table Key Players Fibromuscular Dysplasia Treatment Covered
Table Global Fibromuscular Dysplasia Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Fibromuscular Dysplasia Treatment Market Size Market Share by Type 2014-2025
Figure Surgery Therapy Figures
Table Key Players of Surgery Therapy
Figure Medication Figures
Table Key Players of Medication
Table Global Fibromuscular Dysplasia Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Others Case Studies
Figure Fibromuscular Dysplasia Treatment Report Years Considered
Table Global Fibromuscular Dysplasia Treatment Market Size 2014-2025 (Million US$)
Figure Global Fibromuscular Dysplasia Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Fibromuscular Dysplasia Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Fibromuscular Dysplasia Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Fibromuscular Dysplasia Treatment Market Share by Regions 2014-2019
Figure Global Fibromuscular Dysplasia Treatment Market Share by Regions 2014-2019
Figure Global Fibromuscular Dysplasia Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Fibromuscular Dysplasia Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Fibromuscular Dysplasia Treatment Market Share by Manufacturers (2014-2019)
Figure Global Fibromuscular Dysplasia Treatment Market Share by Manufacturers in 2018
Table Global Fibromuscular Dysplasia Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Fibromuscular Dysplasia Treatment Product/Solution/Service
Table Date of Enter into Fibromuscular Dysplasia Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Fibromuscular Dysplasia Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Fibromuscular Dysplasia Treatment Market Size Share by Type (2014-2019)
Figure Global Fibromuscular Dysplasia Treatment Market Size Market Share by Type (2014-2019)
Table Global Fibromuscular Dysplasia Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Fibromuscular Dysplasia Treatment Market Size Share by Application (2014-2019)
Figure Global Fibromuscular Dysplasia Treatment Market Size Market Share by Application (2014-2019)
Figure Global Fibromuscular Dysplasia Treatment Revenue Market Share by Application in 2018
Figure United States Fibromuscular Dysplasia Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Fibromuscular Dysplasia Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Fibromuscular Dysplasia Treatment Market Share (2018-2019)
Table United States Fibromuscular Dysplasia Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Fibromuscular Dysplasia Treatment Market Share by Type (2014-2019)
Table United States Fibromuscular Dysplasia Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Fibromuscular Dysplasia Treatment Market Share by Application (2014-2019)
Figure Europe Fibromuscular Dysplasia Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Fibromuscular Dysplasia Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Fibromuscular Dysplasia Treatment Market Share (2018-2019)
Table Europe Fibromuscular Dysplasia Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Fibromuscular Dysplasia Treatment Market Share by Type (2014-2019)
Table Europe Fibromuscular Dysplasia Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Fibromuscular Dysplasia Treatment Market Share by Application (2014-2019)
Figure China Fibromuscular Dysplasia Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Fibromuscular Dysplasia Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Fibromuscular Dysplasia Treatment Market Share (2018-2019)
Table China Fibromuscular Dysplasia Treatment Market Size by Type (2014-20189) (Million US$)
Table China Fibromuscular Dysplasia Treatment Market Share by Type (2014-2019)
Table China Fibromuscular Dysplasia Treatment Market Size by Application (2014-2019) (Million US$)
Table China Fibromuscular Dysplasia Treatment Market Share by Application (2014-2019)
Figure Japan Fibromuscular Dysplasia Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Fibromuscular Dysplasia Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Fibromuscular Dysplasia Treatment Market Share (2018-2019)
Table Japan Fibromuscular Dysplasia Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Fibromuscular Dysplasia Treatment Market Share by Type (2014-2019)
Table Japan Fibromuscular Dysplasia Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Fibromuscular Dysplasia Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Fibromuscular Dysplasia Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Fibromuscular Dysplasia Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Fibromuscular Dysplasia Treatment Market Share (2018-2019)
Table Southeast Asia Fibromuscular Dysplasia Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Fibromuscular Dysplasia Treatment Market Share by Type (2014-2019)
Table Southeast Asia Fibromuscular Dysplasia Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Fibromuscular Dysplasia Treatment Market Share by Application (2014-2019)
Figure India Fibromuscular Dysplasia Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Fibromuscular Dysplasia Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Fibromuscular Dysplasia Treatment Market Share (2018-2019)
Table India Fibromuscular Dysplasia Treatment Market Size by Type (2014-2019) (Million US$)
Table India Fibromuscular Dysplasia Treatment Market Share by Type (2014-2019)
Table India Fibromuscular Dysplasia Treatment Market Size by Application (2014-2019) (Million US$)
Table India Fibromuscular Dysplasia Treatment Market Share by Application (2014-2019)
Figure Central & South America Fibromuscular Dysplasia Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Fibromuscular Dysplasia Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Fibromuscular Dysplasia Treatment Market Share (2018-2019)
Table Central & South America Fibromuscular Dysplasia Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Fibromuscular Dysplasia Treatment Market Share by Type (2014-2019)
Table Central & South America Fibromuscular Dysplasia Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Fibromuscular Dysplasia Treatment Market Share by Application (2014-2019)
Table Pfizer Company Details
Table Pfizer Revenue in Fibromuscular Dysplasia Treatment Business (2014-2019) (Million US$)
Figure Pfizer Revenue Growth Rate in Fibromuscular Dysplasia Treatment Business (2014-2019)
Table Pfizer Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Fibromuscular Dysplasia Treatment Business (2014-2019)(Million US$)
Figure Sanofi Revenue Growth Rate in Fibromuscular Dysplasia Treatment Business (2014-2019)
Table Sanofi Recent Development
Table Bayer Company Details
Table Bayer Revenue in Fibromuscular Dysplasia Treatment Business (2014-2019)(Million US$)
Figure Bayer Revenue Growth Rate in Fibromuscular Dysplasia Treatment Business (2014-2019)
Table Bayer Recent Development
Table Merck Company Details
Table Merck Revenue in Fibromuscular Dysplasia Treatment Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Fibromuscular Dysplasia Treatment Business (2014-2019)
Table Merck Recent Development
Table Novartis Company Details
Table Novartis Revenue in Fibromuscular Dysplasia Treatment Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Fibromuscular Dysplasia Treatment Business (2014-2019)
Table Novartis Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Fibromuscular Dysplasia Treatment Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Fibromuscular Dysplasia Treatment Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Fibromuscular Dysplasia Treatment Business (2014-2019)(Million US$)
Figure AstraZeneca Revenue Growth Rate in Fibromuscular Dysplasia Treatment Business (2014-2019)
Table AstraZeneca Recent Development
Table Allergan Company Details
Table Allergan Revenue in Fibromuscular Dysplasia Treatment Business (2014-2019)(Million US$)
Figure Allergan Revenue Growth Rate in Fibromuscular Dysplasia Treatment Business (2014-2019)
Table Allergan Recent Development
Table Medtronic Company Details
Table Medtronic Revenue in Fibromuscular Dysplasia Treatment Business (2014-2019)(Million US$)
Figure Medtronic Revenue Growth Rate in Fibromuscular Dysplasia Treatment Business (2014-2019)
Table Medtronic Recent Development
Table BD Company Details
Table BD Revenue in Fibromuscular Dysplasia Treatment Business (2014-2019)(Million US$)
Figure BD Revenue Growth Rate in Fibromuscular Dysplasia Treatment Business (2014-2019)
Table BD Recent Development
Table Smith & Nephew Company Details
Table Stryker Company Details
Table B. Braun Melsungen Company Details
Table Johnson & Johnson Company Details
Table Hill-Rom Company Details
Table Alkermes Pharma Ireland Company Details
Table Dainippon Sumitomo Pharma Company Details
Table Global Fibromuscular Dysplasia Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Fibromuscular Dysplasia Treatment Market Size Share by Regions (2019-2025)
Figure Global Fibromuscular Dysplasia Treatment Market Size Share by Regions in 2025
Figure United States Fibromuscular Dysplasia Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Fibromuscular Dysplasia Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Fibromuscular Dysplasia Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Fibromuscular Dysplasia Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Fibromuscular Dysplasia Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Fibromuscular Dysplasia Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Fibromuscular Dysplasia Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Fibromuscular Dysplasia Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Fibromuscular Dysplasia Treatment Market Size by Product (2019-2025)
Figure Global Fibromuscular Dysplasia Treatment Market Size by Product in 2025
Table Global Fibromuscular Dysplasia Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Fibromuscular Dysplasia Treatment Market Size by Application (2019-2025)
Figure Global Fibromuscular Dysplasia Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介
  • 世界の獣医整形外科治療市場：市場規模・現状・予測
    Global Veterinary Orthopedic Treatment Market Size, Status and Forecast 2019-2025
    QYR9N8177 2019年6月14日 96Pages
    当資料は、獣医整形外科治療のグローバル市場について調査・分析したレポートで、種類別（十字靭帯裂傷、膝蓋骨贅沢、股関節形成不全、肘異形成、骨折、その他）、用途別（犬、猫、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれて...
  • 世界の腱炎治療市場：市場規模・現状・予測
    Global Tendinitis Treatment Market Size, Status and Forecast 2019-2025
    QYR9N8111 2019年6月14日 93Pages
    当資料は、腱炎治療のグローバル市場について調査・分析したレポートで、種類別（薬、手術療法、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

    ・腱炎治療...
  • 世界のポロ角化症の治療市場：市場規模・現状・予測
    Global Porokeratosis Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7861 2019年6月14日 109Pages
    当資料は、ポロ角化症の治療のグローバル市場について調査・分析したレポートで、種類別（薬、光線力学療法、凍結療法、レーザー、その他）、用途別（病院、診療所、診断センター、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれて...
  • 世界の感覚異常の治療市場：市場規模・現状・予測
    Global Paresthesia Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7765 2019年6月14日 96Pages
    当資料は、感覚異常の治療のグローバル市場について調査・分析したレポートで、種類別（急性感覚異常、慢性感覚異常）、用途別（病院、診療所、診断センター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
  • 世界の髄膜炎菌感染症の治療市場：市場規模・現状・予測
    Global Meningococcal Infections Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7541 2019年6月14日 94Pages
    当資料は、髄膜炎菌感染症の治療のグローバル市場について調査・分析したレポートで、種類別（抗生物質、グルココルチコイド、プロテインC濃縮物）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています...
  • 世界の下垂体の治療市場：市場規模・現状・予測
    Global Hypodontia Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7329 2019年6月14日 93Pages
    当資料は、下垂体の治療のグローバル市場について調査・分析したレポートで、種類別（修復歯科、歯列矯正、口腔外科、その他）、用途別（病院、歯科医院、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
    <...
  • 世界のHIVの診断と治療市場：市場規模・現状・予測
    Global HIV Diagnosis and Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7303 2019年6月14日 95Pages
    当資料は、HIVの診断と治療のグローバル市場について調査・分析したレポートで、種類別（抗体検査、ウイルス同定アッセイ、Cd4テスト、ウイルス負荷試験、早期乳児診断）、用途別（診断研究所、病院、血液銀行、在宅ケアの設定）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場...
  • 世界の汗腺炎掻爬治療市場：市場規模・現状・予測
    Global Hidradenitis Suppurativa Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7295 2019年6月14日 99Pages
    当資料は、汗腺炎掻爬治療のグローバル市場について調査・分析したレポートで、種類別（薬、手術、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

    ・汗腺炎...
  • 世界のフォンヴィレブランド病治療市場：市場規模・現状・予測
    Global Von Willebrand Disease Treatment Market Size, Status and Forecast 2019-2025
    QYR9N8188 2019年6月14日 93Pages
    当資料は、フォンヴィレブランド病治療のグローバル市場について調査・分析したレポートで、種類別（ヴェイヴォンディ、フミン酸-P、英数字、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれてい...
  • 世界のディンプル形成術の治療市場：市場規模・現状・予測
    Global Dimpleplasty Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7109 2019年6月14日 93Pages
    当資料は、ディンプル形成術の治療のグローバル市場について調査・分析したレポートで、種類別（光線療法、レーザー治療、その他）、用途別（病院、皮膚科クリニック、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
  • 世界の転移性骨疾患の治療市場：市場規模・現状・予測世界の転移性骨疾患の治療市場：市場規模・現状・予測 Metastatic bone disease can be quite agonizing to patients, both emotionally and financially, when they discover that their cancer has reached an advanced stage, thereby diminishing their chance of survival and adding to the treatment costs. In 2018, the global Medication Treatment of Metastatic Bon…
  • 世界の転移性骨がんの薬物治療市場：市場規模・現状・予測世界の転移性骨がんの薬物治療市場：市場規模・現状・予測 Bone metastasis occurs when cancer cells spread from their original site to a bone. Nearly all types ofcancer can spread (metastasize) to the bones. But some types of cancer are particularly likely to spread to bone, including breast cancer and prostatecancerIn 2018, the global Metastatic Bones Canc…
  • 世界の獣医整形外科治療市場：市場規模・現状・予測世界の獣医整形外科治療市場：市場規模・現状・予測 Animals commonly suffer from different orthopedic conditions that result in abnormal movement, instability, lameness, and others. Orthopedic conditions such as hip dysplasia, elbow dysplasia, patella luxation, and others require a surgical procedure for the treatment of the condition. The treatment …
  • 世界の腱炎治療市場：市場規模・現状・予測世界の腱炎治療市場：市場規模・現状・予測 Tendinitis is irritation or inflammation of a tendon, a thick cord that attaches muscle to bone. Tendinitis is also called tendonitis. Tendinitis mainly caused due to sudden injury or activities that put stress on the tendons.In 2018, the global Tendinitis Treatment market size was xx million US$ an…
  • 世界のRefsum病治療市場：市場規模・現状・予測世界のRefsum病治療市場：市場規模・現状・予測 Refsum disease, also known as classic or adult Refsum disease, heredopathia atactica polyneuritiformis, phytanic acid oxidase deficiency and phytanic acid storage disease, is an autosomal recessive neurological disease that results in the over-accumulation of phytanic acid in cells and tissues.The A…